Journal
CLINICAL AND VACCINE IMMUNOLOGY
Volume 16, Issue 12, Pages 1829-1831Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/CVI.00191-09
Keywords
-
Categories
Funding
- Cuban Program for Dengue Vaccine Development
Ask authors/readers for more resources
In the present work, we evaluated the neutralizing capacity of the antibodies induced by dengue virus type 1 and 2 envelope domain III recombinant proteins in monkeys against strains of different dengue virus type 1 and 2 genotypes. Here we demonstrated that dengue virus type 1 and 2 recombinant proteins induced high titers of neutralizing antibodies against different genotype strains.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
